Fill S, Malfertheiner M, Costa S-D, Mönkemüller K
Klinik für Gynäkologie und Geburtshilfe, Otto-von-Guericke Universität, Magdeburg, Deutschland.
Z Geburtshilfe Neonatol. 2007 Dec;211(6):215-23. doi: 10.1055/s-2007-981336.
Gastroesophageal reflux disease (GERD) is common during pregnancy. The pathogenesis is a decrease in lower oesophageal sphincter pressure caused by female sex hormones, especially progesterone. The most common symptom of GERD is heartburn. Nevertheless, serious reflux complications during pregnancy are rare. In contrast to non-pregnant patients, GERD during pregnancy should be managed with a step-up algorithm beginning with lifestyle modifications and dietary changes. Antacids or sucralfate are considered the first-line on-demand drug therapy. If symptoms persist, any of the histamine-2-receptor antagonists can be used. Proton pump inhibitors are reserved for women with intractable symptoms or complicated reflux disease. Usually, heartburn during pregnancy resolves soon after delivery but little is known about the late sequelae or, respectively, an influence on subsequent pregnancies. Accordingly a prospective study (longitudinal cohort analysis) is currently underway.
胃食管反流病(GERD)在孕期很常见。其发病机制是女性性激素,尤其是孕酮导致食管下括约肌压力降低。GERD最常见的症状是烧心。然而,孕期严重的反流并发症很少见。与非孕期患者不同,孕期GERD应采用逐步升级的治疗方案,首先从生活方式调整和饮食改变开始。抗酸剂或硫糖铝被视为一线按需药物治疗。如果症状持续,可以使用任何一种组胺-2受体拮抗剂。质子泵抑制剂则留给症状顽固或有复杂反流病的女性。通常,孕期烧心在分娩后很快就会缓解,但对于其晚期后遗症或对后续妊娠的影响知之甚少。因此,目前正在进行一项前瞻性研究(纵向队列分析)。